arrow
Back
A

Anthea Travas

Samsung Medical Center

2H-index
14Paper Count
16Citation Count
Published Papers 3
Publication Date
Prognostic Implication of Framingham Risk Score As a Comorbidity Measure on Treatment Outcomes Following First-Line Tyrosine Kinase Inhibitor in Newly Diagnosed CML Patients
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errChiu, May; Perusini, Maria Agustina; Kim, Jaeyoon John; Pyne, Danielle; Bhatti, Muzaffar; Travas, Anthea; Ayansola, Oyeronke; Ambalavanan, Amirtha; Ho, Jenny; Kim, Dennis Dong Hwan
errShare
errSave
Leptin-Enhanced JAK-STAT Signaling in Acute Myeloid Leukemia-Derived Mesenchymal Stromal Cells and Its Implications for Disease Progression
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errBhatti, Muzaffar; Travas, Anthea; Ayansola, Oyeronke; Ambalavanan, Amirthagowri; Kim, Jaeyoon John; Pyne, Danielle; Ketela, Troy; Arruda, Andrea; Minden, Mark D.; Keating, Armand; Kim, Dennis Dong Hwan
errShare
errSave
In vitro evidence of synergistic efficacy with asciminib combined with reduced dose of ATP-binding pocket tyrosine kinase inhibitors according to the ABL1 kinase domain mutation profile
errLEUKEMIA
IF13.4
err2023-12-28
err1
errOAAI
errHan, Ho-Jae; Kim, Jaeyoon John; Pyne, Danielle; Travas, Anthea; Ambalavanan, Amirthagowri; Kimura, Shinya; Deininger, Michael W.; Kim, Jong-Won; Kim, Dennis Dong Hwan
errShare
errSave